Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $709.17 million for the year ending 2025.
- CATALYST PHARMACEUTICALS, INC. showed an increase of +37.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $5.48 million | Q1 2011: $6.87 million | Q2 2011: $3.41 million | Q3 2011: $2.15 million | Q1 2012: $4.72 million | Q2 2012: $7.51 million | Q3 2012: $11.97 million | Q1 2013: $646.0 thousand | Q2 2013: $879.1 thousand | Q3 2013: $12.96 million | Q1 2014: $1.07 million | Q2 2014: $14.80 million | Q3 2014: $11.26 million | Q1 2015: $41.32 million | Q2 2015: $37.22 million | Q3 2015: $32.75 million | Q1 2016: $22.23 million | Q2 2016: $18.72 million | Q3 2016: $17.64 million | Q1 2017: $9.98 million | Q2 2017: $8.58 million | Q3 2017: $7.33 million | Q1 2018: $19.60 million | Q2 2018: $9.89 million | Q3 2018: $10.62 million | Q1 2019: $19.08 million | Q2 2019: $23.42 million | Q3 2019: $44.98 million | Q1 2020: $101.75 million | Q2 2020: $115.05 million | Q3 2020: $117.11 million | Q1 2021: $127.33 million | Q2 2021: $135.30 million | Q3 2021: $154.84 million | Q1 2022: $178.37 million | Q2 2022: $210.91 million | Q3 2022: $256.07 million | Q1 2023: $148.25 million | Q2 2023: $178.79 million | Q3 2023: $120.97 million | Q1 2024: $310.41 million | Q2 2024: $375.69 million | Q3 2024: $442.33 million | Q1 2025: $580.66 million | Q2 2025: $652.80 million | Q3 2025: $689.89 million.
- Over the full 18 years of available data (2008 to 2025), CATALYST PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 5,927.0%.
- Historical annual values: Fiscal year 2025: $709.17 million | Fiscal year 2024: $517.55 million | Fiscal year 2023: $137.64 million | Fiscal year 2022: $298.40 million | Fiscal year 2021: $171.45 million | Fiscal year 2020: $130.24 million | Fiscal year 2019: $89.51 million | Fiscal year 2018: $16.56 million | Fiscal year 2017: $57.50 million | Fiscal year 2016: $13.89 million | Fiscal year 2015: $28.24 million | Fiscal year 2014: $9.10 million | Fiscal year 2013: $2.22 million | Fiscal year 2012: $1.41 million | Fiscal year 2011: $6.03 million | Fiscal year 2010: $5.48 million | Fiscal year 2009: $7.78 million | Fiscal year 2008: $11.77 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: